Sponsored
Documentation
Vendor-supplied data
COA stated as available
Not independently documented
Checked
Jul 18, 2026
Sleep
Buy Melatonin – Vendors, Prices, Testing and Evidence
Also known as: N-acetyl-5-methoxytryptamine · Circadin (prolonged-release melatonin)
Evidence grade B — Human, limited
Short answer
A hormone, not a peptide, produced by the pineal gland to regulate the sleep-wake cycle. It is well studied for sleep-onset and circadian uses, where effects are consistent but modest; it is over-the-counter in the US but prescription-only in several European countries.
Where can you buy Melatonin?
Crystal Peptides. The table lists only product-specific offers that were checked and for which a real destination exists. Missing prices, quantities, stock and laboratory details are not inferred.
What is known?
Melatonin is a hormone — not a peptide — secreted mainly by the pineal gland in response to darkness, signaling that it is night and helping set the circadian clock. It acts on MT1 and MT2 receptors linked to the brain's master clock in the suprachiasmatic nucleus. It is regulated very differently around the world: an OTC supplement in the US, a prescription medicine in much of Europe.
What is not established?
Comparatively well studied. Meta-analyses of randomized trials in primary sleep disorders find that melatonin modestly shortens the time to fall asleep (on the order of several minutes), modestly increases total sleep time, and improves subjective sleep quality; the absolute benefit is smaller than for standard prescription hypnotics. Evidence is stronger for circadian problems such as jet lag than for chronic insomnia — the American Academy of Sleep Medicine issued a weak recommendation against melatonin for chronic insomnia. A practical problem is product quality: an analysis of US melatonin gummies found actual content ranging from roughly three-quarters to more than three times the labeled amount.
Safety
Melatonin has a favorable short-term safety profile, which is one reason it is often preferred over conventional hypnotics. Common effects are mild and include daytime drowsiness, headache, and dizziness. Because it is a hormone and because OTC labeling can be inaccurate, caution is reasonable for children, during pregnancy, and with long-term use. It can cause drowsiness and should not be combined with alcohol or used before driving.
Regulatory status
A hormone, not a peptide. Regulatory status varies by country: sold over-the-counter as a dietary supplement in the US (not FDA-approved for any medical condition), but prescription-only in the UK and several EU countries. The EMA has approved a prolonged-release melatonin product (Circadin) as a prescription treatment for primary insomnia in adults aged 55 and older.
Not medical advice. This educational reference is not diagnosis, treatment, prescribing, dosing or emergency guidance. Consult a qualified professional before making health-related decisions.
Vendor comparison
Buy Melatonin: compare vendors
The table lists only product-specific offers that were checked and for which a real destination exists. Missing prices, quantities, stock and laboratory details are not inferred.
Affiliate disclosure: This page contains affiliate links. peptides.cx may receive a commission when a purchase is made through one of these links. Evidence ratings, safety summaries and editorial content are produced independently from vendor relationships.
What is it?
Melatonin is a hormone — not a peptide — secreted mainly by the pineal gland in response to darkness, signaling that it is night and helping set the circadian clock. It acts on MT1 and MT2 receptors linked to the brain's master clock in the suprachiasmatic nucleus. It is regulated very differently around the world: an OTC supplement in the US, a prescription medicine in much of Europe.
Research and evidence
Melatonin is a hormone — not a peptide — secreted mainly by the pineal gland in response to darkness. Its job is to signal that it is night and to help set the body's circadian clock, which it does by acting on the MT1 and MT2 receptors linked to the brain's master timekeeper, the suprachiasmatic nucleus. Although it is sold in the same supplement aisles as many peptides and is often lumped in with them, it is a distinct kind of molecule with a specific chronobiological role. It is also regulated very differently around the world: an over-the-counter supplement in the United States, but a prescription medicine in the United Kingdom and several European countries.
Compared with most compounds catalogued here, melatonin is comparatively well studied, and its evidence grade reflects that. Meta-analyses of randomized trials in primary sleep disorders find it modestly shortens the time needed to fall asleep, modestly increases total sleep time, and improves subjective sleep quality — though the absolute benefit is smaller than for standard prescription sleep medicines. The evidence is stronger for circadian problems such as jet lag than for chronic insomnia; the American Academy of Sleep Medicine issued a weak recommendation against using melatonin for chronic insomnia. A practical complication is product quality: one analysis of US melatonin gummies found actual content ranging from about three-quarters to more than three times the labeled amount.
On safety, melatonin has a favorable short-term profile, which is part of why it is often preferred over conventional sleep medications. Common effects are mild and include daytime drowsiness, headache, dizziness, and vivid dreams. Because it is a hormone and because over-the-counter labeling can be inaccurate, caution is reasonable during pregnancy, in children, and with long-term use, and it should not be combined with alcohol or used before driving. Regulatory status varies by country, and the EMA has approved a prolonged-release melatonin product (Circadin) for primary insomnia in adults aged 55 and older. This page is an educational reference, not medical advice, and it does not provide dosing or sourcing guidance.
Evidence grade: B
Comparatively well studied. Meta-analyses of randomized trials in primary sleep disorders find that melatonin modestly shortens the time to fall asleep (on the order of several minutes), modestly increases total sleep time, and improves subjective sleep quality; the absolute benefit is smaller than for standard prescription hypnotics. Evidence is stronger for circadian problems such as jet lag than for chronic insomnia — the American Academy of Sleep Medicine issued a weak recommendation against melatonin for chronic insomnia. A practical problem is product quality: an analysis of US melatonin gummies found actual content ranging from roughly three-quarters to more than three times the labeled amount. Animal studies underpin melatonin's role as a circadian signaling hormone and characterize its MT1/MT2 receptor pharmacology, phase-shifting effects, and antioxidant properties. These models explain how and when melatonin influences sleep timing but are not the primary basis for its human use claims.
Human evidence
Comparatively well studied. Meta-analyses of randomized trials in primary sleep disorders find that melatonin modestly shortens the time to fall asleep (on the order of several minutes), modestly increases total sleep time, and improves subjective sleep quality; the absolute benefit is smaller than for standard prescription hypnotics. Evidence is stronger for circadian problems such as jet lag than for chronic insomnia — the American Academy of Sleep Medicine issued a weak recommendation against melatonin for chronic insomnia. A practical problem is product quality: an analysis of US melatonin gummies found actual content ranging from roughly three-quarters to more than three times the labeled amount.
Animal and preclinical evidence
Animal studies underpin melatonin's role as a circadian signaling hormone and characterize its MT1/MT2 receptor pharmacology, phase-shifting effects, and antioxidant properties. These models explain how and when melatonin influences sleep timing but are not the primary basis for its human use claims.
Proposed mechanisms
- Binds MT1 and MT2 receptors to promote sleep onset and shift circadian timing
- Reinforces the day-night signal from the suprachiasmatic nucleus, acting as a 'chronobiotic'
- Most useful when the internal clock is misaligned, as in jet lag, shift work, or delayed sleep-wake phase disorder
- Has some antioxidant activity in preclinical models, though this is not the basis for its sleep use
Safety concerns and known side effects
Melatonin has a favorable short-term safety profile, which is one reason it is often preferred over conventional hypnotics. Common effects are mild and include daytime drowsiness, headache, and dizziness. Because it is a hormone and because OTC labeling can be inaccurate, caution is reasonable for children, during pregnancy, and with long-term use. It can cause drowsiness and should not be combined with alcohol or used before driving.
- Daytime sleepiness or grogginess
- Headache
- Dizziness
- Vivid dreams, and occasional short-term mood changes
Regulatory status
A hormone, not a peptide. Regulatory status varies by country: sold over-the-counter as a dietary supplement in the US (not FDA-approved for any medical condition), but prescription-only in the UK and several EU countries. The EMA has approved a prolonged-release melatonin product (Circadin) as a prescription treatment for primary insomnia in adults aged 55 and older.
Frequently asked questions about Melatonin
- Is melatonin a peptide?
- No. Melatonin is a hormone, not a peptide. It is produced mainly by the pineal gland in response to darkness and acts on MT1 and MT2 receptors to signal night and help set the circadian clock. It is often sold alongside peptide supplements but is a distinct kind of molecule.
- Does melatonin actually help you sleep?
- The evidence is real but modest. Meta-analyses find melatonin modestly shortens the time to fall asleep, slightly increases total sleep time, and improves subjective sleep quality, with a smaller effect than standard prescription sleep medicines. It works best for circadian issues like jet lag rather than chronic insomnia.
- Is melatonin good for jet lag?
- This is one of its better-supported uses. Evidence is stronger for circadian problems such as jet lag and shift work — where the internal clock is misaligned — than for chronic insomnia, for which a major sleep-medicine body issued a weak recommendation against it.
- Is melatonin available over the counter?
- It depends on the country. Melatonin is sold over the counter as a dietary supplement in the United States, but it is prescription-only in the United Kingdom and several EU countries. The EMA has approved a prolonged-release product (Circadin) for primary insomnia in adults aged 55 and older.
- Is melatonin safe to take?
- It has a favorable short-term safety profile, which is one reason it is often preferred over conventional sleep drugs. Because it is a hormone and OTC labeling can be inaccurate, caution is reasonable during pregnancy, in children, and with long-term use. It can cause drowsiness and should not be mixed with alcohol or used before driving.
- Why do melatonin products vary so much in strength?
- Product quality is a known problem. One analysis of US melatonin gummies found actual content ranging from roughly three-quarters to more than three times the labeled amount, so the stated strength may not match what is in the product. This page is educational and not a substitute for professional medical advice.
- Where can I buy Melatonin and compare vendors?
- Use the vendor comparison on this page. It shows only checked, product-specific links and identifies vendor claims, independent documentation and affiliate relationships separately. Availability and legal status can vary by country.
Common discussion areas
Its use for jet lag and shifting sleep timing versus for general insomniaTiming relative to bedtime and immediate- versus prolonged-release formsWide variation in OTC product content and label accuracyPrescription-only status in Europe versus OTC availability in the US
Sources
Editorial review and transparency
- Written by
- peptides.cx Editorial Team
- Scientific reviewer
- No named medical reviewer is currently assigned
- Last editorial review
- July 18, 2026
- Last vendor check
- July 18, 2026
- Review method
- Source review, claim verification, vendor-data separation and regulatory-context review.
- Commercial disclosure and conflicts
- Vendor relationships do not determine evidence or safety ratings. No named reviewer conflict is recorded because no named reviewer is assigned.